clinical trial · NCT04586166
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
Wake Forest University Health Sciences·N/A·active not recruiting·n = 180
Stress Urinary IncontinencePelvic Floor DisordersRP SlingSIS
brief summary
SASS (Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy) will be a multicenter, prospective, randomized, single-blind non-inferiority trial.
started
Dec 23, 2020
primary completion
Dec 31, 2031
completion
Dec 31, 2032
last updated
Apr 2, 2026
detailed description
SASS aims to compare the efficacy of a single-incision (SIS) versus a retropubic mid-urethral sling (RP) placed at the time of minimally invasive sacrocolpopexy in women with pelvic organ prolapse and objectively confirmed stress urinary incontinence (SUI).
official title
SASS: Randomized Trial of Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for Concomitant Management of Stress Urinary Incontinence During Minimally Invasive Sacrocolpopexy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol